User:David Canner/Sandbox 2
From Proteopedia
< User:David Canner(Difference between revisions)
| Line 5: | Line 5: | ||
{{TOC limit|limit=2}} | {{TOC limit|limit=2}} | ||
| - | + | **Alzheimer’s Disease | |
| - | [[Acetylcholinesterase]] | + | ***[[Acetylcholinesterase]] |
| - | [[Amyloid Beta]] | + | ***[[Amyloid Beta]] |
| - | [[Gamma-Secratase]] | + | ***[[Gamma-Secratase]] |
| - | [[Glutamate receptor (GluA2)]] | + | ***[[Glutamate receptor (GluA2)]] |
| - | + | **Anemia | |
| - | [[Erythropoietin]] | + | ***[[Erythropoietin]] |
| - | + | **Asthma and other Pulmonary Disease States | |
| - | [[Beta-2-Andrenergic Receptor]] | + | ***[[Beta-2-Andrenergic Receptor]] |
| - | [[Leukotriene Receptor]] | + | ***[[Leukotriene Receptor]] |
| - | + | **Autoimmune Diseases | |
| - | [[Tumor Necrosis Factor Receptor]] | + | ***[[Tumor Necrosis Factor Receptor]] |
| - | + | **Blood Clots & Thrombic Events | |
| - | [[P2Y12]] | + | ***[[P2Y12]] |
| - | **Cancer | + | **Cancer |
***Growth Factors | ***Growth Factors | ||
****Epidermal Growth Factor | ****Epidermal Growth Factor | ||
| Line 43: | Line 43: | ||
****[[Phosphatidylinositol 3-Kinase]] | ****[[Phosphatidylinositol 3-Kinase]] | ||
****[[Tyrosine Kinase]] | ****[[Tyrosine Kinase]] | ||
| - | **[[Heat Shock Protein 90]] | + | ***[[Heat Shock Protein 90]] |
| - | **[[p53]] | + | ***[[p53]] |
| - | **[[Mammalian Target of Rapamycin]] | + | ***[[Mammalian Target of Rapamycin]] |
| - | + | **Compromised Immune System | |
| - | [[Granulocyte-macrophage colony-stimulating factor]] | + | ***[[Granulocyte-macrophage colony-stimulating factor]] |
| - | + | **Diabetes & Hypoglycemia | |
| - | [[Peroxisome Proliferator-Activated Receptors]] | + | ***[[Peroxisome Proliferator-Activated Receptors]] |
| - | + | **Digestive Diseases | |
| - | [[Proton Pump]] | + | ***[[Proton Pump]] |
| - | + | **Erectile Dysfunction | |
| - | [[cGMP-Specific Phosphodiesterase Type 5]] | + | ***[[cGMP-Specific Phosphodiesterase Type 5]] |
| - | + | **HIV | |
| - | [[Reverse Transcriptase]] | + | ***[[Reverse Transcriptase]] |
| - | + | **Hypercholesterolemia (Elevated Cholesterol) | |
| - | [[HMG-CoA Reductase]] | + | ***[[HMG-CoA Reductase]] |
| - | + | **Hypertension & Congestive Heart Failure | |
| - | [[Angiotensin-Converting Enzyme]] | + | ***[[Angiotensin-Converting Enzyme]] |
| - | [[Calcium Channel]] | + | ***[[Calcium Channel]] |
| - | + | **Inflammation & Rheumatoid Arthritis | |
| - | [[Cyclooxygenase]] | + | ***[[Cyclooxygenase]] |
| - | + | **Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | |
| - | [[Dopamine Receptor]] | + | ***[[Dopamine Receptor]] |
| - | [[Andrenergic Receptor]] | + | ***[[Andrenergic Receptor]] |
| - | [[Histamine Receptor]] | + | ***[[Histamine Receptor]] |
| - | [[Opioid Receptor]] | + | ***[[Opioid Receptor]] |
}} | }} | ||
Current revision
The following is a list of major phamerceutical compound targets, organized by disease.
